Clinical Trials in Changzhi, 2026
Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.
About this register
This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,282 studies in total at the last sync on 15 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.
This page shows the 27 of those studies with a site in Changzhi.
How many clinical trials are recruiting in Changzhi?
16 of the 27 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.
Summary by phase
| Phase | Studies | Recruiting | Share |
|---|---|---|---|
| Phase 3 | 9 | 4 | 33.3% |
| Observational | 6 | 4 | 22.2% |
| Phase 2 | 4 | 2 | 14.8% |
| Not applicable | 3 | 3 | 11.1% |
| Phase 1/2 | 2 | 2 | 7.4% |
| Phase 1 | 1 | 0 | 3.7% |
| Phase 2/3 | 1 | 0 | 3.7% |
| Phase 4 | 1 | 1 | 3.7% |
Most active sponsors
| Lead sponsor | Studies | Recruiting |
|---|---|---|
| AstraZeneca | 6 | 4 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 | 0 |
| Beijing 302 Hospital | 1 | 0 |
| Beijing University of Chinese Medicine | 1 | 0 |
| Boehringer Ingelheim | 1 | 0 |
| Changzhi People's Hospital Affiliated to Changzhi Medical College | 1 | 1 |
| China-Japan Friendship Hospital | 1 | 1 |
| Chinese PLA General Hospital | 1 | 1 |
| Daiichi Sankyo | 1 | 1 |
| Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 1 | 0 |